转自：北京日报客户端 天安门周边文创又上新了，这次是"纪念中国人民抗日战争暨世界反法西斯战争胜利80周年"纪念徽章。 同时上新的还有"天安门大红灯笼系列·四季天安冰箱贴"的第三枚——"秋吉"冰箱贴。9月13日起，市民 游客可以在天安门广场便民服务车或"中轴之核"微店线上购买。 九三阅兵现场，直升机上悬挂的"正义必胜""和平必胜""人民必胜"条幅让人印象深刻。在抗战胜利80周 年纪念大会徽章上，也能见到这一元素。三个"必胜"做成了标语吊牌垂直排列，让核心精神标语更有仪 式感，也丰富了整个产品的灵动性。 今年春节期间，天安门大红灯笼冰箱贴首发。记者了解到，四季天安系列冰箱贴共有春安、夏泰、秋吉 和冬祥4款，日前，第三枚"秋吉"冰箱贴正式面世。 穆莎莎介绍，和前两枚冰箱贴相比，"秋吉"冰箱贴多了天安门广场大花篮、华灯、和平鸽等经典元素， 并与天安门城楼形成巧妙结合。"从 1986 年开始，天安门广场每年都会为国庆布置大型花坛供人们观 赏，自2012年以来，广场中心花坛一直以大花篮形式呈现。如今，每逢国庆佳节，到天安门广场看大花 篮已然成为一种风潮。" 穆莎莎告诉记者，冰箱贴底部由金色麦穗和长城环抱。麦穗是金秋时节、 ...

配售股份相当于经悉数配发及发行配售股份扩大后的已发行股份总数约16.7%。 公司拟将配售事项所得款项净额的约57.9%用于偿还贷款;约30.9%用于发展农业垂直电商平台及农业低 空经济;及约11.2%用于集团一般营运资金。 智通财经APP讯，从玉智农(00875)发布公告，于2025年9月12日(联交所交易时段后)，公司与配售代理 订立配售协议，据此，公司已有条件同意透过配售代理按竭力基准，以配售价每股配售股份0.29港元向 不少于6名承配人配售最多9102.17万股配售股份。配售价为每股配售股份0.29港元较股份于配售协议日 期于联交所所报的收市价每股0.335港元折让约13.4%。 假设所有配售股份获配售代理成功配售，则配售事项的最高所得款项总额估计约为2640万港元，而经扣 除配售佣金、专业费用及公司可能承担的所有相关开支后，配售事项的最高所得款项净额估计约为2590 万港元。 ...

今年8月19日晚在二季度业绩电话会上，小鹏汽车董事长及首席执行官何小鹏表示，今年四季度，小鹏 汽车将会推出首款鲲鹏超级电动车型小鹏X9，标志着正式开启"一车双能"的产品周期。鲲鹏超电版X9 的纯电续航超过450公里，综合续航超过1500公里，之后还将发布多款超级电动车型产品。到2026年下 半年，小鹏汽车将完成鲲鹏超级电动在海外市场的上市。 新京报贝壳财经讯（记者张冰）9月12日，新京报贝壳财经记者从小鹏汽车获悉，其首款增程SUV小鹏 G7超级增程纯电续航里程将达到430公里，预计将于2026年第一季度正式上市。 ...

格隆汇9月12日丨华润置地(01109.HK)公告，2025年8月，集团经常性收入约人民币42.7亿元，按年增长 6.8%，其中，经营性不动产业务租金收入约人民币28.4亿元，按年增长13.9%。2025年前8月累计经常性 收入约人民币330.5亿元，按年增长7.7%，其中，经营性不动产业务租金收入约人民币214.0亿元，按年 增长12.4%。 ...

Market Performance - The three major stock indices collectively closed lower today, with over 1900 stocks rising, including 74 stocks hitting the daily limit up [1] - Over the past week, all three indices showed gains, with the Shanghai Composite Index rising 1.52%, the Shenzhen Component Index up 2.65%, and the ChiNext Index increasing by 2.1% [2] Stock Movements - A total of 3500 stocks rose this week, with 21 stocks increasing by over 30%. The largest gain was seen in Shannon Chip Creation, which rose by 71.74%, while Shoukai Co., Chunzong Technology, and Qingshan Paper all saw increases of over 52% [3] - Among the stocks that declined, 59 stocks fell by more than 10%, with eight stocks, including Hongyu Packaging and Anzheng Fashion, dropping over 20% [4] Institutional Activity - This week, institutional investors were active in 120 stocks, net buying 54 and net selling 66. Eight stocks saw net purchases exceeding 100 million yuan, with Junsheng Electronics receiving the highest net buy of 412 million yuan, rising 10.86% this week [5] - In total, five stocks saw net sales exceeding 100 million yuan, with Shanghai Washba experiencing the largest net sell of 530 million yuan, despite a 13.35% increase this week [5] Strategic Developments - *ST Dongtong may face mandatory delisting due to significant legal violations [7] - Baoli Technology plans to transfer 40.1% equity of its subsidiary for 1 yuan [8] - Jiangwan Electronics reported normal operations with no undisclosed significant information [10] - Jiangjiawei signed a strategic cooperation agreement with Anchaoyun [11] - Shanghai Mechanical plans to transfer 67% equity of Simik Welding Materials, exiting the non-ferrous welding materials industry [12] Industry Updates - Shandong Gold has terminated its A-share issuance to specific targets and withdrawn its application [18] - Longxin Zhongke expects its 3C6000 and 2K3000 chips to enter mass production next year [18] - Baiyun Airport reported a 4.33% year-on-year increase in passenger throughput for August [17]

智通财经APP讯，华润置地(01109)发布公告，截至2025年8月31日止一个月，本公司及其附属公司(本集 团)实现总合同销售金额约人民币132.0亿元，总合同销售建筑面积约53.9万平方米，分别按年减少13.2% 及26.7%。2025年前8月累计合同销售金额约人民币1,368.0亿元，总合同销售建筑面积约512.0万平方 米，分别按年减少12.0%及23.3%。 2025年8月，本集团经常性收入约人民币42.7亿元，按年增长6.8%，其中，经营性不动产业务租金收入 约人民币28.4亿元，按年增长13.9%。2025年前8月累计经常性收入约人民币330.5亿元，按年增长 7.7%，其中，经营性不动产业务租金收入约人民币214.0亿元，按年增长12.4%。 ...

配售价为每股配售股份0.29港元，较股份于配售协议日期于联交所所报收市价每股0.335港元折让约 13.4%；假设所有配售股份获配售代理成功配售，则配售事项最高所得款项总额估计约为2640万港元， 而经扣除配售佣金、专业费用及公司可能承担所有相关开支后，配售事项最高所得款项净额估计约为 2590万港元。 格隆汇9月12日丨从玉智农(00875.HK)公告，于2025年9月12日，公司与配售代理订立配售协议，据此， 公司已有条件同意透过配售代理按竭力基准，以配售价每股配售股份0.29港元向不少于六(6)名承配人 (彼等及彼等最终实益拥有人须为独立第三方)配售最多91,021,689股配售股份。配售股份将根据股东周 年大会上授予董事的一般授权配发及发行。配发及发行配售股份毋须经股东批准。 ...

华润置地(01109)发布公告，截至20258月31日止一个月，本公司及其附属公司(本集团)实现总合同销售 金额约人民币132.0亿元，总合同销售建筑面积约53.9万平方米，分别按年减少13.2%及26.7%。2025前8 月累计合同销售金额约人民币1,368.0亿元，总合同销售建筑面积约512.0万平方米，分别按年减少12.0% 及23.3%。 20258月，本集团经常性收入约人民币42.7亿元，按年增长6.8%，其中，经营性不动产业务租金收入约 人民币28.4亿元，按年增长13.9%。2025前8月累计经常性收入约人民币330.5亿元，按年增长7.7%，其 中，经营性不动产业务租金收入约人民币214.0亿元，按年增长12.4%。 ...

Core Insights - The launch of Menarini's new product, the Beshuhen® silicone gel scar patch, on JD Health marks a significant step in scar management and reflects the growing market demand for effective scar treatment solutions [2][3] - The scar management market is experiencing rapid growth, with JD Health reporting a compound annual growth rate of 62% in scar removal market sales from 2019 to 2024 [2] - The Beshuhen® silicone gel scar patch incorporates multiple technological innovations to meet consumer demands for adhesion, durability, soothing care, and natural appearance [2] Company and Industry Developments - Menarini aims to leverage its global clinical research capabilities and local insights in collaboration with JD Health to promote a comprehensive scar management approach focused on early prevention and intervention [2][3] - JD Health plans to continue its partnership with Menarini and other global medical device brands to establish a new product launch IP aimed at transforming scar management from reactive repair to proactive prevention [3]

Core Insights - The launch of the new product,倍舒痕®硅凝胶疤痕贴, by Menarini on JD Health marks a significant step in scar management, leveraging Menarini's clinical research capabilities and JD Health's digital marketing ecosystem [1][2] - The scar management market is experiencing rapid growth, with a projected compound annual growth rate (CAGR) of 62% in sales from 2019 to 2024 according to the "China Skin Scar White Paper" released by JD Health and Menarini [1] - The new product features multiple technological innovations to meet consumer demands for adhesion, durability, soothing care, and natural appearance [1] Company and Industry Developments - Menarini aims to enhance consumer access to innovative scar management solutions through collaboration with JD Health, promoting early and scientific scar management [2] - JD Health plans to continue its partnership with global medical device brands to establish a new product launch IP, focusing on transforming scar management from passive repair to scientific prevention [2]